3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
36
Rectal Neoplasms
23
Stomach Neoplasms
19
Triple Negative Breast Neoplasms
16
Colorectal Neoplasms
14
Neoplasm Metastasis
12
Adenocarcinoma
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Pancreatic Neoplasms
7
Esophageal Neoplasms
7
Adenocarcinoma Of Esophagus
7
Nasopharyngeal Carcinoma
6
Colonic Neoplasms
6
Biliary Tract Neoplasms
6
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Pathologic Complete Response
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Locally Advanced Rectal Cancer
2
Cholangiocarcinoma
2
Carcinoma
2
Bile Duct Neoplasms
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Interventions
pembrolizumab
28
Cisplatin
19
Carboplatin
14
Radiotherapy
11
Paclitaxel
10
Cetuximab
10
Surveys and Questionnaires
7
Radiotherapy, Intensity-Modulated
5
Docetaxel
5
Surgical Procedures, Operative
4
Fluorouracil
4
Chemoradiotherapy
4
dostarlimab
3
Therapeutics
3
Nivolumab
3
Drug Therapy
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
tislelizumab
2
nimotuzumab
2
cemiplimab
2
abemaciclib
2
X-Rays
2
Taxes
2
Standard of Care
2
Radiosurgery
2
Radiation
2
Pemetrexed
2
Methotrexate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Capecitabine
×
90 days
×
Clear all
No trials found.